Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically lll adults.

Background And Objectives: Disease biomarkers require appropriate clinical context to be used effectively. Combining clinical risk factors, in addition to small changes in serum creatinine, has been proposed to improve the assessment of AKI. This notion was developed in order to identify the risk of AKI early in a patient's clinical course.